Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Tomas Hruby, Ricard Ferrer et al.|Critical Care|2022Cited by 93
Genetic effects on gene expression across human tissuesEric Haugen, Peter F. Hickey, Yuan He et al.|UNC Libraries|2020Cited by 62